MethylDetect –
Your Source for DNA Methylation Assays

DNA Methylation is one of the most widely studied epigenetic mechanisms of gene expression regulation. Aberrant methylation of increasing number of genes is being shown to contribute to the majority of diseases from cancer, inflammatory, autoimmune and metabolic diseases through environmental related diseases to psychiatric disorders.

Solid research evidence already shows that DNA methylation-based biomarkers can be utilized at all stages of clinical disease management including:

  • Disease risk assessment
  • Early detection
  • Personalization of treatment
  • Monitoring of chronic disorders and recurrence

MethylDetect offers ready-to-use kits for detection of aberrant gene methylation. The kits are based on the MS-HRM (Methylation Sensitive High Resolution Melting) technology and can be used with standard laboratory equipment. Additionally, our new controls system shipped with each kit, provides state-of-the-art experimental reliability.

Learn more about MS-HRM ressources:

6 days ago
@MethylDetect to Sponsor and Exhibit at #4BIO Summit:Europe, Rotterdam 27-28 November by @lifesciences_GE
7 days ago
Tomasz will speak at @HighTechDTU in the session: Biomarkers – The key to personalized health (Organized by Med Tech Innovation & Biopeople) @HighTechDTU @biopeopledk @AarhusUni @AIAS_dk #dkforsk #dkdigi #dkbiz
2 weeks ago
Chronic lymphocytic leukemia patients with heterogeneously or fully methylated LPL promotor display longer time to treatment.
https://t.co/AXLEzOusXa

#Cancer , #blood , #biomarkers , #treatment

Methylation detection with MethylDetect’s Kit

1. ADD: The MethylDetect kit components to the bisulfite-modified biological sample and PCR reagents
2. AMPLIFY: Use standard laboratory Real Time-PCR system to PCR amplify the target
3. DETECT: Assess the methylation status of the sequence of interest with a High-Resolution Melting module